Patent details

Basic Information

Publication number:

EP2525776

PCT Application Number:

PCT/US/2011/021971

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117017236

PCT Publication Number:

WO/2011/091205

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS

French Title of Invention:

IMPLANTS INTRACAMÉRULAIRES CONTENANT UN AGENT THÉRAPEUTIQUE À LIBÉRATION PROLONGÉE

German Title of Invention:

INTRAKAMERALE IMPLANTATE MIT RETARD-THERAPEUTIKA

SPC Number:

Dates

Filing date:

21/01/2011

Grant date:

28/10/2015

EP Publication Date:

28/10/2015

PCT Publication Date:

28/07/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/11/2012

EP B1 Publication Date:

28/10/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/01/2016

Expiration date:

21/01/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/01/2011

 

 

Name:

ALLERGAN INC.

Address:

2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

1

Name:

BURKE James

Address:

United States (US)

2

Name:

ROBINSON Michael R.

Address:

United States (US)

3

Name:

SCHIFFMAN Rhett

Address:

United States (US)

4

Name:

GHEBREMESKEL Alazar N.

Address:

United States (US)

Priority

Priority Number:

297660 P

Priority Date:

22/01/2010

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages